PHE has undertaken rapid assessments of commercially provided diagnostic tests for SARS-CoV-2 nucleic acid detection with further evaluations ongoing. Category: UncategorisedBy 22 February 2021Leave a commentPost navigationPreviousPrevious post:Guidance: Alpha zero thalassaemia carrier: description in briefNextNext post:Form: QuantiFERON®-TB Gold test request form
